Celsion CEO Michael Tardugno - An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Tardugno speaks with the DAILY about the regulatory timeline and commercialization plans for ThermoDox, including plans to market the heat-activated liposomal-delivery doxorubicin in Asia.